Concepedia

John D. Campbell

JD

36

Publications

2.4K

Citations

26

H-Index

1975

Active since

Affiliations

Dynavax Technologies (United States)(Current)

University of Manitoba

Miltenyi Biotec (Germany)

Temple University

Washington University in St. Louis

John D. Campbell is an author at Dynavax Technologies (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1975–2024

36

Publications

36

The β-Chemokine Receptor D6 Is Expressed by Lymphatic Endothelium and a Subset of Vascular Tumors

Robert J. B. Nibbs, Ernst Kriehuber, Paul Ponath et al. · American Journal Of Pathology · 2001 · 265 citations · Full text

, , +8

Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression

John D. Campbell, Karen Buckland, Sarah J. McMillan et al. · The Journal of Experimental Medicine · 2009 · 207 citations · Full text

Matrix Metalloproteinase-9 Deficiency Results in Enhanced Allergen-Induced Airway Inflammation

Sarah J. McMillan, Jennifer Kearley, John D. Campbell et al. · The Journal of Immunology · 2004 · 184 citations · Full text

Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19

Tsun-Yung Kuo, Meei-Yun Lin, Robert L. Coffman et al. · Scientific Reports · 2020 · 179 citations · Full text

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants

Georg Rauser, Hermann Einsele, Christian Sinzger et al. · Blood · 2003 · 166 citations · Full text

Rows per page

1–5 of 36